
AstraZeneca is transitioning 16,000 vehicles in its global fleet to battery-electric assets following the company's move to join the EV100.
AstraZeneca is transitioning 16,000 vehicles in its global fleet to battery-electric assets following the company's move to join the EV100.
Looking ahead, how will procurement and fleet evolve in the future? My prediction is there will be market forces (both internal and external), along with technological enhancements, that will facilitate a much closer collaboration between the two disciplines using a combination of in-house and outsourced expertise.
The secure and easy all-access connection to your content.
Bookmarked content can then be accessed anytime on all of your logged in devices!
Already a member? Log In